Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
Hugh J FreemanDepartment of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada Abstract: In selected patients with moderate to severe active ulcerative colitis who have failed to respond or are poorly responsive to standard pharmacologic forms of treatment with cortic...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-11-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/developments-in-the-treatment-of-moderate-to-severe-ulcerative-colitis-a14932 |